Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Beta Group is a privately held innovation and business development company that creates, acquires, patents, finances, and commercializes technologies across multiple sectors, including medical devices and ophthalmology. The company describes itself as operating at the earliest stages of development, using a long-cycle "Inventrepreneur" model to bring ideas from concept through beta testing and toward commercialization. In healthcare, it has been associated with the creation or co-founding of several device-oriented ventures and products, including nitinol-based ophthalmic frames, cardiovascular stent technology, orthopedic implants, and other medical device businesses. The company appears to function more as a venture creation and commercialization platform than as a single-product biotech or pharmaceutical developer. It is private, multi-sector, and active, with healthcare representing one of several areas of focus rather than its sole business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Beta Group.